Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director comp.
Appointed director
Inv. presentation
Quarterly results
Amneal Pharmaceuticals, Inc. (AMRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/04/2023 8-K Quarterly results
Docs: "AMNEAL REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS"
05/19/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Notice of Pendency of Settlement of Derivative Action"
05/12/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/05/2023 8-K Quarterly results
Docs: "AMNEAL REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS"
04/17/2023 8-K Quarterly results
03/02/2023 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "AMNEAL REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS"
01/10/2023 8-K Quarterly results
11/04/2022 8-K Quarterly results
09/06/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Employment Agreement dated September 1, 2022, by and between Amneal Pharmaceuticals, Inc. and Gustavo Pesquin",
"Amneal Appoints Gustavo Pesquin as Executive Vice President, Chief Commercial Officer - Specialty September 6, 2022"
08/05/2022 8-K Quarterly results
08/03/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Amneal Appoints Deborah M. Autor to Board of Directors"
07/19/2022 8-K Quarterly results
06/02/2022 8-K Quarterly results
05/13/2022 8-K Quarterly results
05/04/2022 8-K Quarterly results
03/16/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
03/02/2022 8-K Quarterly results
01/11/2022 8-K Results of Operations and Financial Condition, Regulation FD Disclosure  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
01/05/2022 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "Asset Purchase Agreement, by and among Amneal and Saol Therapeutics",
"Amneal Acquires Saol Therapeutics’ Baclofen Franchise (furnished pursuant to Item 7.01)"
11/03/2021 8-K Quarterly results
Docs: "AMNEAL REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS"
08/09/2021 8-K Quarterly results
05/10/2021 8-K Quarterly results
05/07/2021 8-K Quarterly results
04/05/2021 8-K Quarterly results
02/26/2021 8-K Quarterly results
02/16/2021 8-K Quarterly results
01/12/2021 8-K Quarterly results
12/18/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
11/06/2020 8-K Quarterly results
Docs: "AMNEAL REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS"
08/06/2020 8-K Quarterly results
08/04/2020 8-K Quarterly results
05/11/2020 8-K Quarterly results
Docs: "AMNEAL REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS"
05/08/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
04/17/2020 8-K/A Financial Statements and Exhibits  Interactive Data
Docs: "Consent of Crowe LLP - AvKARE, Inc",
"Consent of Crowe LLP - Dixon-Shane, LLC",
"Audited Financial Statements of AvKARE, Inc. as of December 31, 2019 and for the year then ended",
"Audited Financial Statements of Dixon-Shane, LLC dba R&S Northeast LLC as of December 31, 2019 and for the year then ended",
"Unaudited Pro Forma Condensed Combined Financial Information of Amneal Pharmaceuticals, Inc. as of December 31, 2019 and for the year then ended December 31, 2019"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy